Crizotinib is a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK). Crizotinib is a potential antitumor agent.
We supply our existing products steadily and provide continuous and perfect after-sales service to help our customers solve all kinds of questions during the process of using the products.
We pay close attention to the international and domestic market trends constantly, enriching the latest products reserve for future use to provide customers with more updated choice of pharmaceutical intermediates and nutrition ingredients.
We continue to research and practice to improve product performances such as Solubility, bioavailability, hygroscopicity…etc to make our products more in line with customer application requirements.
We also provide full customize service such as research and develop, laboratorysmall-scale trial test, scale up production and cost accounting according to the chemical structure, quantityand quality requirements provided by our customers.
